Skip to main content
Top
Published in: BMC Infectious Diseases 1/2014

Open Access 01-12-2014 | Research article

A novel method for detection of HBVcccDNA in hepatocytes using rolling circle amplification combined with in situ PCR

Authors: Yanwei Zhong, Shuangye Hu, Chen Xu, Yulai Zhao, Dongping Xu, Yanqing Zhao, Jingmin Zhao, Zhibin Li, Xiuchang Zhang, Hongfei Zhang, Jin Li

Published in: BMC Infectious Diseases | Issue 1/2014

Login to get access

Abstract

Background

Intrahepatic hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) is the original template for HBV replication. The persistence of cccDNA is responsible for the recurrence of HBV infection. The detection of cccDNA can help the development of new antiviral drugs against HBV replication links, and reduce the resistance and recurrence as well as to discover extrahepatic HBV infection. In situ polymerase chain reaction (IS-PCR) can be used to determine the distribution and localization of cccDNA in liver tissues, but it is hampered by its low sensitivity and specificity. We developed a novel method to detect HBV cccDNA using rolling circle amplification (RCA) combined with IS-PCR.

Methods

Biopsy liver tissues were obtained from 26 patients with HBV infection, including 10 chronic hepatitis B (CHB), 6 liver cirrhosis (LC) and 10 hepatocellular carcinoma (HCC) patients. Four pairs of primers were designed to mediating RCA for the first round amplification of HBV cccDNA specifically. The liver tissue sections from patients were treated by plasmid-safe ATP-dependent DNase (PSAD) prior to RCA. After RCA, HBV cccDNA was further amplified by a pair of selective primers labeled digoxigenin that target the gap region between the two direct repeat regions (DR1 and DR2) of the virus via IS-PCR.

Results

HBVcccDNA was expressed and located in hepatocyte nucleus in 19 patients (73.07%). Compared with the IS-PCR, the introduction of RCA increase the limit of detection. RCA combined with IS-PCR yielded strong positive signals in HCC liver tissue in spite of low copy number cccDNA (2 copies of target sequence per cell), meanwhile, no positive signal was detected via negative control.

Conclusions

RCA combined with IS-PCR is an effective and practicable method which could detect the presence of low copy number of cccDNA sensitively and specifically, and reflect the relationship between cccDNA expression level and liver tissue pathological characteristics.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hosaka T, Suzuki F, Kobayashi M, Seko Y, Kawamura Y, Sezaki H, Akuta N, Suzuki Y, Saitoh S, Arase Y, Ikeda K, Kobayashi M, Kumada H: Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection. Hepatology. 2013, 58 (1): 98-107. 10.1002/hep.26180.CrossRefPubMed Hosaka T, Suzuki F, Kobayashi M, Seko Y, Kawamura Y, Sezaki H, Akuta N, Suzuki Y, Saitoh S, Arase Y, Ikeda K, Kobayashi M, Kumada H: Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection. Hepatology. 2013, 58 (1): 98-107. 10.1002/hep.26180.CrossRefPubMed
2.
go back to reference Zhong Y, Lv J, Li J, Xing X, Zhu H: Prevalence, virology and antiviral drugs susceptibility of hepatitis B virus rtN238H polymerase mutation from 1865 Chinese patients with chronic hepatitis B. Antiviral Res. 2012, 93: 185-190. 10.1016/j.antiviral.2011.11.012.CrossRefPubMed Zhong Y, Lv J, Li J, Xing X, Zhu H: Prevalence, virology and antiviral drugs susceptibility of hepatitis B virus rtN238H polymerase mutation from 1865 Chinese patients with chronic hepatitis B. Antiviral Res. 2012, 93: 185-190. 10.1016/j.antiviral.2011.11.012.CrossRefPubMed
3.
go back to reference Zhong YW, Li J, Song HB, Duan ZP, Dong Y: Virologic and clinical characteristics of HBV genotypes/subgenotypes in 487 Chinese pediatric patients with CHB. BMC Infect Dis. 2011, 11: 262-10.1186/1471-2334-11-262.CrossRefPubMedPubMedCentral Zhong YW, Li J, Song HB, Duan ZP, Dong Y: Virologic and clinical characteristics of HBV genotypes/subgenotypes in 487 Chinese pediatric patients with CHB. BMC Infect Dis. 2011, 11: 262-10.1186/1471-2334-11-262.CrossRefPubMedPubMedCentral
4.
go back to reference Lin YJ, Lee MH, Yang HI, Jen CL, You SL: Predictability of liver-related Seromarkers for the risk of hepatocellular carcinoma in chronic hepatitis B patients. PLoS One. 2013, 8 (4): e61448-10.1371/journal.pone.0061448. doi:10.1371CrossRefPubMedPubMedCentral Lin YJ, Lee MH, Yang HI, Jen CL, You SL: Predictability of liver-related Seromarkers for the risk of hepatocellular carcinoma in chronic hepatitis B patients. PLoS One. 2013, 8 (4): e61448-10.1371/journal.pone.0061448. doi:10.1371CrossRefPubMedPubMedCentral
5.
go back to reference Locarnini S, Hatzakis A, Heathcote J, Keeffe EB, Liang TJ: Management of antiviral resistance in patients with chronic hepatitis B. Antivir Ther. 2004, 9: 679-693.PubMed Locarnini S, Hatzakis A, Heathcote J, Keeffe EB, Liang TJ: Management of antiviral resistance in patients with chronic hepatitis B. Antivir Ther. 2004, 9: 679-693.PubMed
7.
go back to reference Pawlotsky JM, Dusheiko G, Hatzakis A, Lau D, Lau G: Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized. Gastroenterology. 2008, 134: 405-415. 10.1053/j.gastro.2007.11.036.CrossRefPubMed Pawlotsky JM, Dusheiko G, Hatzakis A, Lau D, Lau G: Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized. Gastroenterology. 2008, 134: 405-415. 10.1053/j.gastro.2007.11.036.CrossRefPubMed
8.
go back to reference Werle-Lapostolle B, Bowden S, Locarnini S, Wursthorn K, Petersen J: Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology. 2004, 126: 1750-1758. 10.1053/j.gastro.2004.03.018.CrossRefPubMed Werle-Lapostolle B, Bowden S, Locarnini S, Wursthorn K, Petersen J: Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology. 2004, 126: 1750-1758. 10.1053/j.gastro.2004.03.018.CrossRefPubMed
9.
go back to reference Lenci I, Marcuccilli F, Tisone G, Di Paolo D, Tariciotti L: Total and covalently closed circular DNA detection in liver tissue of long-term survivors transplanted for HBV-related cirrhosis. Dig Liver Dis. 2010, 42: 578-584. 10.1016/j.dld.2009.12.003.CrossRefPubMed Lenci I, Marcuccilli F, Tisone G, Di Paolo D, Tariciotti L: Total and covalently closed circular DNA detection in liver tissue of long-term survivors transplanted for HBV-related cirrhosis. Dig Liver Dis. 2010, 42: 578-584. 10.1016/j.dld.2009.12.003.CrossRefPubMed
10.
go back to reference Lu L, Zhang HY, Yueng YH, Cheung KF, Luk JM: Intracellular levels of hepatitis B virus DNA and pregenomic RNA in peripheral blood mononuclear cells of chronically infected patients. J Viral Hepat. 2009, 16: 104-112. 10.1111/j.1365-2893.2008.01054.x.CrossRefPubMed Lu L, Zhang HY, Yueng YH, Cheung KF, Luk JM: Intracellular levels of hepatitis B virus DNA and pregenomic RNA in peripheral blood mononuclear cells of chronically infected patients. J Viral Hepat. 2009, 16: 104-112. 10.1111/j.1365-2893.2008.01054.x.CrossRefPubMed
11.
go back to reference Wong DK, Yuen MF, Yuan H, Sum SS, Hui CK: Quantitation of covalently closed circular hepatitis B virus DNA in chronic hepatitis B patients. Hepatology. 2004, 40: 727-737. 10.1002/hep.20353.CrossRefPubMed Wong DK, Yuen MF, Yuan H, Sum SS, Hui CK: Quantitation of covalently closed circular hepatitis B virus DNA in chronic hepatitis B patients. Hepatology. 2004, 40: 727-737. 10.1002/hep.20353.CrossRefPubMed
12.
go back to reference Laras A, Koskinas J, Dimou E, Kostamena A, Hadziyannis SJ: Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients. Hepatology. 2006, 44: 694-702. 10.1002/hep.21299.CrossRefPubMed Laras A, Koskinas J, Dimou E, Kostamena A, Hadziyannis SJ: Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients. Hepatology. 2006, 44: 694-702. 10.1002/hep.21299.CrossRefPubMed
13.
go back to reference Wursthorn K, Lutgehetmann M, Dandri M, Volz T, Buggisch P: Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B. Hepatology. 2006, 44: 675-684. 10.1002/hep.21282.CrossRefPubMed Wursthorn K, Lutgehetmann M, Dandri M, Volz T, Buggisch P: Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B. Hepatology. 2006, 44: 675-684. 10.1002/hep.21282.CrossRefPubMed
14.
go back to reference Zhong Y, Han J, Zou Z, Liu S, Tang B: Quantitation of HBV covalently closed circular DNA in micro formalin fixed paraffin-embedded liver tissue using rolling circle amplification in combination with real-time PCR. Clin Chim Acta. 2012, 412: 1905-1911. 10.1016/j.cca.2011.06.031.CrossRef Zhong Y, Han J, Zou Z, Liu S, Tang B: Quantitation of HBV covalently closed circular DNA in micro formalin fixed paraffin-embedded liver tissue using rolling circle amplification in combination with real-time PCR. Clin Chim Acta. 2012, 412: 1905-1911. 10.1016/j.cca.2011.06.031.CrossRef
15.
go back to reference Bowden S, Jackson K, Littlejohn M, Locarnini S: Quantification of HBV covalently closed circular DNA from liver tissue by real-time PCR. Methods Mol Med. 2004, 95: 41-50.PubMed Bowden S, Jackson K, Littlejohn M, Locarnini S: Quantification of HBV covalently closed circular DNA from liver tissue by real-time PCR. Methods Mol Med. 2004, 95: 41-50.PubMed
16.
go back to reference Singh M, Dicaire A, Wakil AE, Luscombe C, Sacks SL: Quantitation of hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) in the liver of HBV-infected patients by LightcyclerTM real-time PCR. J Virol Methods. 2004, 118: 159-167. 10.1016/j.jviromet.2004.02.006.CrossRefPubMed Singh M, Dicaire A, Wakil AE, Luscombe C, Sacks SL: Quantitation of hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) in the liver of HBV-infected patients by LightcyclerTM real-time PCR. J Virol Methods. 2004, 118: 159-167. 10.1016/j.jviromet.2004.02.006.CrossRefPubMed
17.
go back to reference Takkenberg RB, Zaaijer HL, Menting S, Weegink CJ, Terpstra V: Detection of hepatitis B virus covalently closed circular DNA in paraffin-embedded and cryo-preserved liver biopsies of chronic hepatitis B patients. Eur J Gastroenterol Hepatol. 2010, 22: 952-960. 10.1097/MEG.0b013e3283376a63.CrossRefPubMed Takkenberg RB, Zaaijer HL, Menting S, Weegink CJ, Terpstra V: Detection of hepatitis B virus covalently closed circular DNA in paraffin-embedded and cryo-preserved liver biopsies of chronic hepatitis B patients. Eur J Gastroenterol Hepatol. 2010, 22: 952-960. 10.1097/MEG.0b013e3283376a63.CrossRefPubMed
18.
go back to reference Zhang DY, Brandwein M, Hsuih T, Li HB: Ramification amplification: a novel isothermal DNA amplification method. Mol Diagn. 2001, 6: 141-150. 10.2165/00066982-200106020-00010.CrossRefPubMed Zhang DY, Brandwein M, Hsuih T, Li HB: Ramification amplification: a novel isothermal DNA amplification method. Mol Diagn. 2001, 6: 141-150. 10.2165/00066982-200106020-00010.CrossRefPubMed
19.
go back to reference Lasken RS, Egholm M: Whole genome amplification: abundant supplies of DNA from precious samples or clinical specimens. Trends Biotechnol. 2003, 21: 531-535. 10.1016/j.tibtech.2003.09.010.CrossRefPubMed Lasken RS, Egholm M: Whole genome amplification: abundant supplies of DNA from precious samples or clinical specimens. Trends Biotechnol. 2003, 21: 531-535. 10.1016/j.tibtech.2003.09.010.CrossRefPubMed
20.
go back to reference Margeridon S, Carrouee-Durantel S, Chemin I, Barraud L, Zoulim F: Rolling circle amplification, a powerful tool for genetic and functional studies of complete hepatitis B virus genomes from low-level infections and for directly probing covalently closed circular DNA. Antimicrob Agents Chemother. 2008, 52: 3068-3073. 10.1128/AAC.01318-07.CrossRefPubMedPubMedCentral Margeridon S, Carrouee-Durantel S, Chemin I, Barraud L, Zoulim F: Rolling circle amplification, a powerful tool for genetic and functional studies of complete hepatitis B virus genomes from low-level infections and for directly probing covalently closed circular DNA. Antimicrob Agents Chemother. 2008, 52: 3068-3073. 10.1128/AAC.01318-07.CrossRefPubMedPubMedCentral
21.
go back to reference Su HL, Liu YM, Ren XQ, Xu DP, Zhong YW: Comparative analysis of drug resistant mutations in the reverse transcriptase domain of hepatitis B virus covalently closed circular DNA and the viral relax circle DNA. Chin J Hepatol. 2010, 8: 818-821. Su HL, Liu YM, Ren XQ, Xu DP, Zhong YW: Comparative analysis of drug resistant mutations in the reverse transcriptase domain of hepatitis B virus covalently closed circular DNA and the viral relax circle DNA. Chin J Hepatol. 2010, 8: 818-821.
22.
go back to reference Johne R, Muller H, Rector A, van Ranst M, Stevens H: Rolling-circle amplification of viral DNA genomes using phi29 polymerase. Trends Microbiol. 2009, 17: 205-211. 10.1016/j.tim.2009.02.004.CrossRefPubMed Johne R, Muller H, Rector A, van Ranst M, Stevens H: Rolling-circle amplification of viral DNA genomes using phi29 polymerase. Trends Microbiol. 2009, 17: 205-211. 10.1016/j.tim.2009.02.004.CrossRefPubMed
23.
go back to reference Haase AT, Retzel EF, Staskus KA: Amplification and detection of lentiviral DNA inside cells. Proc Natl Acad Sci U S A. 1990, 87: 4971-4975. 10.1073/pnas.87.13.4971.CrossRefPubMedPubMedCentral Haase AT, Retzel EF, Staskus KA: Amplification and detection of lentiviral DNA inside cells. Proc Natl Acad Sci U S A. 1990, 87: 4971-4975. 10.1073/pnas.87.13.4971.CrossRefPubMedPubMedCentral
24.
go back to reference Shieh B, Lee SE, Tsai YC, Su IJ, Li C: Detection of hepatitis B virus genome in hepatocellular carcinoma tissues with PCR-in situ hybridization. J Virol Methods. 1990, 80: 157-167. 10.1016/S0166-0934(99)00040-3.CrossRef Shieh B, Lee SE, Tsai YC, Su IJ, Li C: Detection of hepatitis B virus genome in hepatocellular carcinoma tissues with PCR-in situ hybridization. J Virol Methods. 1990, 80: 157-167. 10.1016/S0166-0934(99)00040-3.CrossRef
25.
go back to reference Alzahrani AJ, Vallely PJ, McMahon RF: Development of a novel nested in situ PCR-ISH method for detection of hepatitis C virus RNA in liver tissue. J Virol Methods. 2002, 99: 53-61. 10.1016/S0166-0934(01)00383-4.CrossRefPubMed Alzahrani AJ, Vallely PJ, McMahon RF: Development of a novel nested in situ PCR-ISH method for detection of hepatitis C virus RNA in liver tissue. J Virol Methods. 2002, 99: 53-61. 10.1016/S0166-0934(01)00383-4.CrossRefPubMed
26.
go back to reference Nuriya H, Inoue K, Tanaka T, Hayashi Y, Hishima T: Detection of hepatitis B and C viruses in almost all hepatocytes by modified PCR-based in situ hybridization. J Clin Microbiol. 2010, 48: 3843-3851. 10.1128/JCM.00415-10.CrossRefPubMedPubMedCentral Nuriya H, Inoue K, Tanaka T, Hayashi Y, Hishima T: Detection of hepatitis B and C viruses in almost all hepatocytes by modified PCR-based in situ hybridization. J Clin Microbiol. 2010, 48: 3843-3851. 10.1128/JCM.00415-10.CrossRefPubMedPubMedCentral
27.
go back to reference Asan E: Progress in focus: recent advances in histochemistry and cell biology. Histochem Cell Biol. 2002, 118: 507-525.PubMed Asan E: Progress in focus: recent advances in histochemistry and cell biology. Histochem Cell Biol. 2002, 118: 507-525.PubMed
28.
go back to reference Nuovo GJP: The utility of in situ-based methodologies including in situ polymerase chain reaction for the diagnosis and study of viral infections. Hum Pathol. 2007, 38: 1123-1136. 10.1016/j.humpath.2007.04.005.CrossRefPubMed Nuovo GJP: The utility of in situ-based methodologies including in situ polymerase chain reaction for the diagnosis and study of viral infections. Hum Pathol. 2007, 38: 1123-1136. 10.1016/j.humpath.2007.04.005.CrossRefPubMed
29.
go back to reference Teo IA, Shaunak S: Polymerase chain reaction in situ: an appraisal of an emerging technique. Histochem J. 1995, 27: 647-659.PubMed Teo IA, Shaunak S: Polymerase chain reaction in situ: an appraisal of an emerging technique. Histochem J. 1995, 27: 647-659.PubMed
30.
go back to reference Nuovo GJ, Gallery F, Hom R, MacConnell P, Bloch W: Importance of different variables for enhancing in situ detection of PCR-amplified DNA. PCR Methods Appl. 1993, 2: 305-312. 10.1101/gr.2.4.305.CrossRefPubMed Nuovo GJ, Gallery F, Hom R, MacConnell P, Bloch W: Importance of different variables for enhancing in situ detection of PCR-amplified DNA. PCR Methods Appl. 1993, 2: 305-312. 10.1101/gr.2.4.305.CrossRefPubMed
31.
go back to reference Zaki SR, Heneine W, Coffield LM, Greer PW, Sinha SD: In-situ polymerase chain reaction amplification: applications and current limitations. AIDS. 1994, 8: 1186-1187.PubMed Zaki SR, Heneine W, Coffield LM, Greer PW, Sinha SD: In-situ polymerase chain reaction amplification: applications and current limitations. AIDS. 1994, 8: 1186-1187.PubMed
Metadata
Title
A novel method for detection of HBVcccDNA in hepatocytes using rolling circle amplification combined with in situ PCR
Authors
Yanwei Zhong
Shuangye Hu
Chen Xu
Yulai Zhao
Dongping Xu
Yanqing Zhao
Jingmin Zhao
Zhibin Li
Xiuchang Zhang
Hongfei Zhang
Jin Li
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2014
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-014-0608-y

Other articles of this Issue 1/2014

BMC Infectious Diseases 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.